PHAT (Phathom Pharmaceuticals, Inc. Common Stock)

Insider Trading Activity

Every open-market purchase and sale reported by PHAT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
50
most recent
Open-Market Buys
5
code P
Sales
4
code S
Reporting Insiders
22
current holders
PHAT — Recent Form 4 Transactions (latest 2026-09-08)
FiledInsiderRole TypeSharesValue
2026-09-08 Robert Charles Breedlove Principal Accounting Officer F
2026-07-16 Robert Charles Breedlove Principal Accounting Officer F
2026-05-27 Asit Parikh Director G
2026-05-21 MICHAEL F COLA Director A
2026-05-21 FRANK KARBE Director A
2026-05-21 Mark Stenhouse Director A
2026-05-21 Theodore R Schroeder Director A
2026-05-21 James N Topper Director A
2026-05-21 Asit Parikh Director MIXED
2026-05-21 HEIDI FIELDS Director A
2026-03-11 Asit Parikh Director G
2026-03-03 Robert Charles Breedlove Principal Accounting Officer MIXED
2026-02-12 Steven L Basta President and CEO MIXED
2026-02-12 Anne Marie Cook Chief Legal Off. & Corp. Sec. MIXED
2026-01-27 Asit Parikh Director G
2026-01-23 Robert Charles Breedlove Principal Accounting Officer F
2026-01-15 Asit Parikh Director M
2026-01-02 Sanjeev Narula Chief Financial & Bus. Officer A
2026-01-02 Steven L Basta President and CEO A
2026-01-02 Anne Marie Cook Chief Legal Off. & Corp. Sec. A
2025-12-23 Asit Parikh Director M
2025-12-19 Anne Marie Cook Chief Legal Off. & Corp. Sec. MIXED
2025-12-19 Steven L Basta President and CEO MIXED
2025-12-19 Robert Charles Breedlove Principal Accounting Officer F
2025-12-02 Steven L Basta President and CEO MIXED
2025-11-05 Robert Charles Breedlove Principal Accounting Officer Sell
2025-10-08 Sanjeev Narula Chief Financial & Bus. Officer A
2025-10-07 Sanjeev Narula Chief Financial & Bus. Officer A
2025-09-26 Steven L Basta President and CEO MIXED
2025-09-09 Robert Charles Breedlove Principal Accounting Officer Sell
2025-07-18 Robert Charles Breedlove Principal Accounting Officer Sell
2025-06-24 Anne Marie Cook Chief Legal Off. & Corp. Sec. A
2025-06-05 Asit Parikh Director A
2025-06-05 MICHAEL F COLA Director A
2025-06-05 HEIDI FIELDS Director A
2025-06-05 James N Topper Director A
2025-06-05 FRANK KARBE Director A
2025-06-05 Mark Stenhouse Director A
2025-05-23 James N Topper Director Buy
2025-05-21 Robert Charles Breedlove Principal Accounting Officer A
2025-05-15 James N Topper Director Buy
2025-05-13 James N Topper Director Buy
2025-05-08 Asit Parikh Director Buy
2025-04-16 Theodore R Schroeder Director A
2025-04-08 Molly Henderson CFO and CBO Sell
2025-04-03 Steven L Basta President and CEO A
2025-03-21 Asit Parikh Director M
2025-03-17 Asit Parikh Director Buy
2025-03-03 Terrie Curran President and Chief Executive A
2025-03-03 Azmi Nabulsi Chief Operating Officer A
PHAT — Current Insider Holders
InsiderRole Shares HeldValue
10%+ Owner 5,842,352
10%+ Owner 3,825,008
10%+ Owner 3,755,583
10%+ Owner 3,707,408
10%+ Owner 3,115,008
Director 1,230,846
Chief Operating Officer 1,098,290
Director 991,672
President and CEO 373,315
President and Chief Executive 364,305
Chief Financial & Bus. Officer 226,715
Director 172,622
Director 126,121
CFO and CBO 91,779
Director 91,622
Chief Legal Off. & Corp. Sec. 88,660
Principal Accounting Officer 67,656
Director 63,920
Director 54,122
Director 54,122
Director 45,122
VP, Chief Accounting Officer 8,862
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the PHAT quote page; the site-wide leaderboard is on the insider transactions hub.